Standout Papers

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement 2009 2026 2014 2020 72.7k
  1. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)
    David Moher, A. Liberati et al. BMJ
  2. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)
    David Moher, Alessandro Liberati et al. PLoS Medicine
  3. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)
    David Moher, Alessandro Liberati et al. PubMed
  4. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)
    David Moher et al. Annals of Internal Medicine
  5. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials (2011)
    Julian P. T. Higgins, Doug Altman et al. BMJ
  6. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)
    Alessandro Liberati, Douglas G. Altman et al. PLoS Medicine
  7. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement (2015)
    David Moher, Larissa Shamseer et al. Systematic Reviews
  8. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)
    David Moher, Alessandro Liberati et al. Journal of Clinical Epidemiology
  9. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)
    A. Liberati, Doug Altman et al. BMJ
  10. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)
    Kenneth F. Schulz, Douglas G. Altman et al. BMC Medicine
  11. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation (2015)
    Larissa Shamseer, David Moher et al. BMJ
  12. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement (2010)
    David Moher, Alessandro Liberati et al. International Journal of Surgery
  13. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration (2009)
    Alessandro Liberati, Douglas G. Altman et al. Journal of Clinical Epidemiology
  14. The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)
    Alessandro Liberati, Douglas G. Altman et al. Annals of Internal Medicine
  15. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)
    David Moher, Sally Hopewell et al. BMJ
  16. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017)
    Beverley Shea, Barnaby C Reeves et al. BMJ
  17. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide (2014)
    Tammy Hoffmann, Paul Glasziou et al. BMJ
  18. The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations (2015)
    Brian Hutton, Georgia Salanti et al. Annals of Internal Medicine
  19. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials (2011)
    Jonathan A C Sterne, Alex J. Sutton et al. BMJ
  20. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials (2013)
    An‐Wen Chan, Jennifer Tetzlaff et al. Annals of Internal Medicine
  21. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)
    David Moher, Kenneth F. Schulz et al. The Lancet
  22. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)
    David Moher, Fadi Hammal et al. The Lancet
  23. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials (2013)
    A.-W. Chan, Jennifer Tetzlaff et al. BMJ
  24. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement (2015)
    Eric I. Benchimol, Liam Smeeth et al. PLoS Medicine
  25. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews (2007)
    Beverley Shea, Jeremy Grimshaw et al. BMC Medical Research Methodology
  26. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? (1998)
    David Moher, Ba’ Pham et al. The Lancet
  27. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials (2001)
    David Moher, Kenneth F. Schulz et al. BMC Medical Research Methodology
  28. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration (2009)
    Alessandro Liberati, Douglas G. Altman et al. Italian Journal of Public Health
  29. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies (2015)
    Patrick M. Bossuyt, Johannes B. Reitsma et al. BMJ
  30. The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials (2001)
    David Moher JAMA
  31. Scoping reviews: time for clarity in definition, methods, and reporting (2014)
    Heather Colquhoun, Danielle Levac et al. Journal of Clinical Epidemiology
  32. Reprint—Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)
    David Moher, Alessandro Liberati et al. Physical Therapy
  33. Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration (2008)
    Isabelle Boutron, David Moher et al. Annals of Internal Medicine
  34. CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials (2010)
    Kenneth F. Schulz, Douglas G. Altman et al. PLoS Medicine
  35. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials (2011)
    David Moher, Sally Hopewell et al. International Journal of Surgery
  36. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement (2021)
    Matthew J. Page, Joanne E. McKenzie et al. Journal of Clinical Epidemiology
  37. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials (2010)
    Kenneth F. Schulz, Douglas G. Altman et al. Journal of Pharmacology and Pharmacotherapeutics
  38. A comparison of direct vs. self‐report measures for assessing height, weight and body mass index: a systematic review (2007)
    Sarah Connor Gorber, Mark S. Tremblay et al. Obesity Reviews
  39. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)
    Don Husereau, Michael Drummond et al. Value in Health
  40. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)
    Don Husereau, Michael Drummond et al. BMJ
  41. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)
    David Moher, Sally Hopewell et al. Journal of Clinical Epidemiology
  42. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)
    Kenneth F. Schulz, Douglas G. Altman et al. Trials
  43. Improving the reporting of pragmatic trials: an extension of the CONSORT statement (2008)
    Merrick Zwarenstein, Shaun Treweek et al. BMJ
  44. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research (2017)
    Sophie Staniszewska, Jo Brett et al. Research Involvement and Engagement
  45. Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists (1995)
    David Moher, Alejandro R. Jadad et al. Controlled Clinical Trials
  46. The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials (2001)
    David Moher, Kenneth F. Schulz et al. Annals of Internal Medicine
  47. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT Statement (2010)
    Hugh MacPherson, Douglas G. Altman et al. PLoS Medicine
  48. GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research (2017)
    Sophie Staniszewska, Jo Brett et al. BMJ
  49. Increasing value and reducing waste in research design, conduct, and analysis (2014)
    John P. A. Ioannidis, Sander Greenland et al. The Lancet
  50. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews (2012)
    Alison Booth, Mike Clarke et al. Systematic Reviews
  51. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies (2015)
    Patrick M. Bossuyt, Johannes B. Reitsma et al. Radiology
  52. A catalogue of reporting guidelines for health research (2009)
    Iveta Simera, David Moher et al. European Journal of Clinical Investigation
  53. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts (2017)
    Isabelle Boutron, Douglas G. Altman et al. Annals of Internal Medicine
  54. Reporting of Patient-Reported Outcomes in Randomized Trials (2013)
    Melanie Calvert, Jane Blazeby et al. JAMA
  55. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials (2011)
    Kenneth F. Schulz, Douglas G. Altman et al. International Journal of Surgery
  56. Evidence summaries: the evolution of a rapid review approach (2012)
    Sara D. Khangura, Kristin J. Konnyu et al. Systematic Reviews
  57. The CARE guidelines: consensus-based clinical case reporting guideline development (2013)
    Joel Gagnier, Gunver S. Kienle et al. Journal of Medical Case Reports
  58. Reducing waste from incomplete or unusable reports of biomedical research (2014)
    Paul Glasziou, Douglas G. Altman et al. The Lancet
  59. Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled Trials (2012)
    Jelena Savović, Hayley E Jones et al. Annals of Internal Medicine
  60. Guidance for Developers of Health Research Reporting Guidelines (2010)
    David Moher, Kenneth F. Schulz et al. PLoS Medicine
  61. Use of the CONSORT Statement and Quality of Reports of Randomized Trials (2001)
    David Moher, Alison Jones et al. JAMA
  62. CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials (2010)
    Kenneth F. Schulz, Douglas G. Altman et al. Journal of Clinical Epidemiology
  63. A scoping review of rapid review methods (2015)
    Andrea C. Tricco, Jesmin Antony et al. BMC Medicine
  64. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (Chinese edition) (2009)
    David Moher Journal of Chinese Integrative Medicine
  65. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies (2015)
    Patrick M. Bossuyt, Johannes B. Reitsma et al. Clinical Chemistry
  66. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. (2003)
    Patrick M. Bossuyt, Johannes B. Reitsma et al. PubMed
  67. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review (2006)
    Amy C. Plint, David Moher et al. The Medical Journal of Australia
  68. Epidemiology and Reporting Characteristics of Systematic Reviews (2007)
    David Moher, Jennifer Tetzlaff et al. PLoS Medicine
  69. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? (2000)
    Laura McAuley, Ba’ Pham et al. The Lancet
  70. How Quickly Do Systematic Reviews Go Out of Date? A Survival Analysis (2007)
    Kaveh G Shojania, Margaret Sampson et al. Annals of Internal Medicine
  71. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals (2012)
    Lucy Turner, Larissa Shamseer et al. Cochrane Database of Systematic Reviews
  72. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. (2012)
    Jelena Savović, Hayley E Jones et al. Health Technology Assessment
  73. PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity (2012)
    Vivian Welch, Mark Petticrew et al. PLoS Medicine
  74. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement (2013)
    Don Husereau, Michael Drummond et al. Value in Health
  75. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis (2012)
    Andrea C. Tricco, Noah Ivers et al. The Lancet
  76. An evidence-based practice guideline for the peer review of electronic search strategies (2009)
    Margaret Sampson, Jessie McGowan et al. Journal of Clinical Epidemiology
  77. Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study (2016)
    Matthew J. Page, Larissa Shamseer et al. PLoS Medicine
  78. Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review (2017)
    Matthew J. Page, David Moher Systematic Reviews
  79. CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT (2013)
    Don Husereau, Michael Drummond et al. International Journal of Technology Assessment in Health Care
  80. La extensión de la declaración PRISMA para revisiones sistemáticas que incorporan metaanálisis en red: PRISMA-NMA (2016)
    Brian Hutton, Ferrán Catalá-López et al. Medicina Clínica
  81. Preferred reporting items for systematic reviews and meta‐analyses in ecology and evolutionary biology: a PRISMA extension (2021)
    Rose E. O’Dea, Malgorzata Lagisz et al. Biological reviews/Biological reviews of the Cambridge Philosophical Society

Immediate Impact

7 from Science/Nature 91 standout
Sub-graph 1 of 22

Citing Papers

Meta-analysis reveals global variations in plant diversity effects on productivity
2025 StandoutNature
Functional traits—not nativeness—shape the effects of large mammalian herbivores on plant communities
2024 StandoutScience
31 intermediate papers

Works of David Moher being referenced

Preferred reporting items for systematic reviews and meta‐analyses in ecology and evolutionary biology: a PRISMA extension
2021 Standout
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
2011 Standout
and 44 more

Author Peers

Author Last Decade Papers Cites
David Moher 30710 64744 53281 85588 55854 775 488.1k
Douglas G. Altman 30291 70289 50990 105792 71964 632 585.5k
Matthias Egger 8665 24340 18280 35836 31896 751 204.3k
Peter C Gøtzsche 9159 24974 18184 39970 25014 276 196.6k
Jennifer Tetzlaff 7161 32288 25039 49346 31669 40 265.9k
George Davey Smith 2580 31623 19839 22578 25688 2.0k 209.0k
Gordon Guyatt 12338 23232 20565 32454 22197 1.3k 166.8k
Julian P. T. Higgins 9063 16645 8389 31545 21573 446 178.4k
Alessandro Liberati 4985 23493 18211 33889 21926 84 187.2k
John P. A. Ioannidis 18083 20022 12957 25317 17450 1.1k 180.8k
Walter C. Willett 457 95400 11419 18445 20188 1.9k 246.6k

All Works

Loading papers...

Rankless by CCL
2026